Are insulin sensitizers the new strategy to treat Type 1 diabetes? A long-acting dual amylin and calcitonin receptor agonist improves insulin-mediated glycaemic control and controls body weight.

Humulin R (recombinant human insulin) - Alzheimer's Disease Cooperative Study, Eli Lilly

Symlin (pramlintide) - AstraZeneca

http://www.ncbi.nlm.nih.gov/pubmed/38378168

Anna Thorsø Larsen; Kim Henriksen; Morten Asser Karsdal; Simone Anna Melander

Feb 21, 2024